臨床路徑在社區獲得性肺炎中的應用_《中國呼吸與危重監護雜志》

作者：

朱迎鋼 , 瞿介明

復旦大學附屬華東醫院呼吸內科（上海 200040）通訊作者：瞿介明，E-mail：jmqu64@yahoo.com.cn;

關鍵詞：

臨床路徑社區獲得性肺炎

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

社區獲得性肺炎( CAP) 是嚴重威脅人類健康的常見疾病之一, 但在其診斷和治療仍存在相當大的差異。臨床路徑( clinical pathway, CP) 是一種新的臨床診療規范管理方式,
近年來開始應用于CAP 的臨床診治, 陸續有協會組織開始制定關于CAP 的臨床路徑, 并應用于臨床。

引用本文： 朱迎鋼,瞿介明. 臨床路徑在社區獲得性肺炎中的應用. 中國呼吸與危重監護雜志, 2010, 9(1): 97-99. doi: 復制

1.	Bartlett JG,Dowell SF,Mandell LA,et al.Practice guidelines for the management of community-acquired pneumonia in adults.Infectious Diseases Society of America.Clin Infect Dis,2000,31:347-382.
2.	Hauck LD,Adler LM,Mulla ZD.Clinical pathway care improves outcomes among patients hospitalized for community-acquired pneumonia.Ann Epidemiol,2004,14:669-675.
3.	Lave JR,Lin CJ,Hughes CP,et al.The cost of treating patients with community-acquired pneumonia.Semin Respir Crit Care Med,1999,20:189-197.
4.	龔棣.介紹一種新的醫療護理模式——臨床路徑.現代醫院管理,2004,2:42-44.
5.	吳袁俞云,英立平.臨床路徑實施手冊.北京:北京醫科大學出版社,2002.
6.	王冬,董軍,朱士俊.臨床路徑——臨床醫療的標準化管理模式.醫院管理論壇,2003,19:38-42.
7.	Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250.
8.	Meehan TP,Weingarten SR,Holmboe ES,et al.A statewide initiative to improve the care of hospitalized pneumonia patients:The Connecticut Pneumonia Pathway Project.Am J Med,2001,111:203-210.
9.	Marrie TJ,Lau CY,Wheeler SL,et al.A controlled trial of a critical pathway for treatment of community-acquired pneumonia.CAPITAL Study Investiga tors.Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.JAMA,2000,283:749-755.
10.	Carusone SC,Loeb M,Lohfeld L.A clinical pathway for treating pneumonia in the nursing home:part I:the nursing perspective.J Am Med Dir Assoc,2006,7:271-278.
11.	Carusone SC,Loeb M,Lohfeld L.A clinical pathway for treating pneumonia in the nursing home:part II:the administrators’ perspective and how it differs from nurses’ views.J Am Med Dir Assoc,2006,7:279-286.
12.	孫宏永,徐峰,徐志豪,等.社區獲得性肺炎臨床路徑的初步探討.浙江醫學,2007,29:805-806.
13.	Barlow G,Nathwani D,Williams F,et al.Reducing door-to-antibiotic time in community-acquired pneumonia:Controlled before-and-after evaluation and cost-effectiveness analysis.Thorax,2007,62:67-74.
14.	Ramirez JA. Switch therapy in community-acquired pneumonia. Diagn Microbiol Infect Dis,1995,22: 219-223.
15.	Moeller JJ,Ma M,Hernandez P,et al.Discharge Delay in Patients with Community-acquired Pneumonia Managed on a Critical Pathway.Can J Infect Dis Med Microbiol,2006,17:109-113.
16.	Masotti L,Ceccarelli E,Cappelli R,et al.Length of hospitalization in elderly patients with community-acquired pneumonia.Aging (Milano),2000,12:35-41.
17.	Brancati FL,Chow JW,Wagener MM,,et al.Is pneumonia really the old man’s friend? Two-year prognosis after community-acquired pneumonia.Lancet,1993,342:30-33.
18.	Marrie TJ.Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia.Chemotherapy,2004,50 suppl 1:11-15.
19.	Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
20.	Mandell LA,Wunderink RG,Anzueto A,et al.Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.Clin Infect Dis,2007,44 Suppl 2:S27-72.
21.	Moran G.Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones.J Emerg Med,2006,30:377-387.

1. Bartlett JG,Dowell SF,Mandell LA,et al.Practice guidelines for the management of community-acquired pneumonia in adults.Infectious Diseases Society of America.Clin Infect Dis,2000,31:347-382.
2. Hauck LD,Adler LM,Mulla ZD.Clinical pathway care improves outcomes among patients hospitalized for community-acquired pneumonia.Ann Epidemiol,2004,14:669-675.
3. Lave JR,Lin CJ,Hughes CP,et al.The cost of treating patients with community-acquired pneumonia.Semin Respir Crit Care Med,1999,20:189-197.
4. 龔棣.介紹一種新的醫療護理模式——臨床路徑.現代醫院管理,2004,2:42-44.
5. 吳袁俞云,英立平.臨床路徑實施手冊.北京:北京醫科大學出版社,2002.
6. 王冬,董軍,朱士俊.臨床路徑——臨床醫療的標準化管理模式.醫院管理論壇,2003,19:38-42.
7. Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250.
8. Meehan TP,Weingarten SR,Holmboe ES,et al.A statewide initiative to improve the care of hospitalized pneumonia patients:The Connecticut Pneumonia Pathway Project.Am J Med,2001,111:203-210.
9. Marrie TJ,Lau CY,Wheeler SL,et al.A controlled trial of a critical pathway for treatment of community-acquired pneumonia.CAPITAL Study Investiga tors.Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.JAMA,2000,283:749-755.
10. Carusone SC,Loeb M,Lohfeld L.A clinical pathway for treating pneumonia in the nursing home:part I:the nursing perspective.J Am Med Dir Assoc,2006,7:271-278.
11. Carusone SC,Loeb M,Lohfeld L.A clinical pathway for treating pneumonia in the nursing home:part II:the administrators’ perspective and how it differs from nurses’ views.J Am Med Dir Assoc,2006,7:279-286.
12. 孫宏永,徐峰,徐志豪,等.社區獲得性肺炎臨床路徑的初步探討.浙江醫學,2007,29:805-806.
13. Barlow G,Nathwani D,Williams F,et al.Reducing door-to-antibiotic time in community-acquired pneumonia:Controlled before-and-after evaluation and cost-effectiveness analysis.Thorax,2007,62:67-74.
14. Ramirez JA. Switch therapy in community-acquired pneumonia. Diagn Microbiol Infect Dis,1995,22: 219-223.
15. Moeller JJ,Ma M,Hernandez P,et al.Discharge Delay in Patients with Community-acquired Pneumonia Managed on a Critical Pathway.Can J Infect Dis Med Microbiol,2006,17:109-113.
16. Masotti L,Ceccarelli E,Cappelli R,et al.Length of hospitalization in elderly patients with community-acquired pneumonia.Aging (Milano),2000,12:35-41.
17. Brancati FL,Chow JW,Wagener MM,,et al.Is pneumonia really the old man’s friend? Two-year prognosis after community-acquired pneumonia.Lancet,1993,342:30-33.
18. Marrie TJ.Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia.Chemotherapy,2004,50 suppl 1:11-15.
19. Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
20. Mandell LA,Wunderink RG,Anzueto A,et al.Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.Clin Infect Dis,2007,44 Suppl 2:S27-72.
21. Moran G.Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones.J Emerg Med,2006,30:377-387.

《中國呼吸與危重監護雜志》

臨床路徑在社區獲得性肺炎中的應用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《中國呼吸與危重監護雜志》

臨床路徑在社區獲得性肺炎中的應用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料